Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Moodys
Baxter
Merck
McKesson
Colorcon

Last Updated: December 14, 2019

DrugPatentWatch Database Preview

Litigation Details for Spectrum Pharmaceuticals Inc v. InnoPharma Inc. (D. Del. 2012)

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

Spectrum Pharmaceuticals Inc v. InnoPharma Inc. (D. Del. 2012)

Docket   Start Trial Date Filed 2012-03-02
Court District Court, D. Delaware Date Terminated 2015-08-04
Cause 35:271 Patent Infringement Assigned To Richard Gibson Andrews
Jury Demand None Referred To Christopher J. Burke
Parties INNOPHARMA INC.; MYLAN INSTITUTIONAL INC.; MYLAN INSTITUTIONAL LLC; MYLAN TEORANTA; SPECTRUM PHARMACEUTICALS INC; UNIVERSITY OF STRATHCLYDE
Patents 6,500,829
Attorneys Barry M. Klayman; Bindu Ann George Palapura; Jack B. Blumenfeld; Richard Charles Weinblatt; Rodger Dallery Smith , II
Link to Docket External link to docket
Small Molecule Drugs cited in Spectrum Pharmaceuticals Inc v. InnoPharma Inc.
The small molecule drug covered by the patent cited in this case is   Start Trial .

Details for Spectrum Pharmaceuticals Inc v. InnoPharma Inc. (D. Del. 2012)

Date Filed Document No. Description Snippet Link To Document
2014-12-02 239 of Invalidity of Claims 1 and 2 of U.S. Patent No. 6,500,829 by Mylan Institutional Inc., Mylan Institutional…2012 4 August 2015 1:12-cv-00260 830 Patent None District Court, D. Delaware External link to document
2014-12-09 242 of Invalidity of Claims 1 and 2 of U.S. Patent No. 6,500,829 filed by Mylan Institutional Inc., Mylan…2012 4 August 2015 1:12-cv-00260 830 Patent None District Court, D. Delaware External link to document
2014-12-09 243 Noninfringement of Claims 5 through 14 of U.S. Patent No. 6,500,829 filed by Mylan Institutional Inc., Mylan…2012 4 August 2015 1:12-cv-00260 830 Patent None District Court, D. Delaware External link to document
2014-12-12 246 Noninfringement of Claims 5 through 14 of U.S. Patent No. 6,500,829. (Palapura, Bindu) (Entered: 12/12/2014)…the '829 Patent, 196 MOTION for Summary Judgment of Invalidity of Claims 1 and 2 of U.S. Patent No. 6,500,829…2012 4 August 2015 1:12-cv-00260 830 Patent None District Court, D. Delaware External link to document
2014-12-17 250 of Invalidity of Claims 1 and 2 of U.S. Patent No. 6,500,829. (Attachments: # 1 Revised Version of Opening…2012 4 August 2015 1:12-cv-00260 830 Patent None District Court, D. Delaware External link to document
2014-12-18 251 of Invalidity of Claims 1 and 2 of U.S. Patent No. 6,500,829 filed by Mylan Institutional Inc., Mylan…2012 4 August 2015 1:12-cv-00260 830 Patent None District Court, D. Delaware External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
AstraZeneca
Mallinckrodt
McKinsey
Colorcon
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.